Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach

por Garonzik, Samira M., Lenhard, Justin R., Forrest, Alan, Holden, Patricia N., Bulitta, Jϋrgen B., Tsuji, Brian T.
Publicado 2016

2547. Targeting penicillin-binding protein 2 (PBP2) to treat metallo-beta-lactamase (MBL)-producing Klebsiella pneumoniae: Mecillinam as an American Ninja Warrior

por Klem, Jack F, Candidate, Pharm D, Kaur, Jan Naseer, Smith, Nicholas M, Chen, Al, Holden, Patricia N, Bulitta, Jürgen B, Tsuji, Brian T
Publicado 2023

2170. It takes two to tango: ß-lactam/ß-lactamase inhibitor combinations targeting metallo-ß-lactamase (MBL)- producing Klebsiella pneumoniae.

por Kaur, Jan Naseer, Klem, Jack F, Singh, Navaldeep, Holden, Patricia N, Cha, Raymond, Chen, Liang, Kreiswirth, Barry N, Smith, Nicholas M, Tsuji, Brian T
Publicado 2023

1325. Things that go Bump in the Night: Combating Klebsiella pneumoniae co-producing New Delhi metallo-beta-lactamase (NDM) and Mobile Colistin Resistance (MCR)

por Smith, Nicholas M, Chen, Liang, Boissonneault, Katie Rose, Lodise, Thomas, Holden, Patricia N, Bulitta, Juergen B, Bonomo, Robert A, Kreiswirth, Barry N, Tsuji, Brian T
Publicado 2020

Polymyxin Combinations Combat Escherichia coli Harboring mcr-1 and bla(NDM-5): Preparation for a Postantibiotic Era

por Bulman, Zackery P., Chen, Liang, Walsh, Thomas J., Satlin, Michael J., Qian, Yuli, Bulitta, Jürgen B., Peloquin, Charles A., Holden, Patricia N., Nation, Roger L., Li, Jian, Kreiswirth, Barry N., Tsuji, Brian T.
Publicado 2017